Dexcom Inc., a company that makes continuous glucose monitoring devices for patients with diabetes, reported a net loss of $12.9 million on revenue of $72.8 million for the first quarter of 2015 – a 55 percent growth in revenue year-over-year.
In the same quarter of 2014, the company reported a net loss of $12.5 million on $47.1 million in revenue.
Shares of Dexcom are trading on the NasdaqGS for $67.13 under the stock symbol DXCM.